Loading resource…

Duke Cancer Institute, Durham, North Carolina, USA
As cancer survival rates improve, the incidence of cardiovascular complications related to cancer therapies has become a significant concern. This text discusses the cardiotoxic effects of various chemotherapeutic agents and radiation therapy, emphasizing the need for vigilant cardiovascular monitoring in cancer survivors. It includes guidelines for screening and management strategies to mitigate cardiovascular risks associated with cancer treatments.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology

OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology

CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology

The Athlete’s ECG
Same clinical topic · Cardiology

Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology

Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology

Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology

INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology

atherosclerosis-BK Presentation for Microlabs
Same clinical topic · Cardiology